Related Experiment Video
Updated: May 23, 2026
Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
Published on: July 25, 2011
Tissue inhibitor of metalloproteinases in oral squamous cell carcinomas - a therapeutic target?
Mario Pérez-Sayáns1, José Manuel Suárez-Peñaranda2, Pilar Gayoso-Diz3
1Oral Medicine, Oral Surgery and Implantology Unit, Faculty of Medicine and Dentistry, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain; Entrerríos s/n, Santiago de Compostela C.P. 15782, Spain.
Abstract:
Matrix metalloproteinases (MMPs) are proteases responsible for remodeling the extracellular matrix (ECM) and enabling spreading and metastasis of tumor cells, a common phenomenon in oral squamous cell carcinomas (OSCC). They are strongly blocked by several inhibitors, among which we must highlight, for their specificity and potency, the endogenous tissue inhibitors of metalloproteinases (TIMP-1, -2, -3 and -4). The goal of this paper is to describe the expression of TIMPs in OSCC, determining their relation with clinical, histological and prognostic factors, delving into OSCC regulation mechanisms and discussing the use of exogenous TIMPs to treat this type of tumors. Expression of TIMPs in OSCC is higher in tumors than in normal tissue, which correlates with an increase of metastatic risk and regional lymph node affectation. Although some metalloproteinases inhibitors (MMIs) have shown promising results in the treatment of these tumors, their use in OSCC has not been widely tested; and although some indirect MMIs, like COX-2 inhibitors, flavonoids and endostatin seem to have beneficial effects on the invasive capacity of OSCC through regulation of MMPs and TIMP levels, routine clinical use has not been accepted yet.
Insights
Tissue inhibitors of metalloproteinases (TIMPs) are elevated in oral squamous cell carcinomas (OSCC), correlating with increased metastatic risk. Further research is needed to explore exogenous TIMPs for OSCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) are key enzymes in extracellular matrix remodeling, crucial for tumor cell invasion and metastasis in oral squamous cell carcinomas (OSCC).
- Endogenous tissue inhibitors of metalloproteinases (TIMPs) are specific and potent inhibitors of MMPs, playing a critical role in regulating their activity.
Purpose of the Study:
- To investigate the expression patterns of TIMPs in OSCC.
- To determine the correlation between TIMP expression and clinical, histological, and prognostic factors in OSCC.
- To explore the potential of exogenous TIMPs as a therapeutic strategy for OSCC.
Main Methods:
- Analysis of TIMP expression levels in OSCC tissues compared to normal tissues.
- Correlation analysis between TIMP expression and clinicopathological parameters.
- Review of existing literature on metalloproteinase inhibitors (MMIs) and their efficacy in OSCC.
Main Results:
- TIMP expression is significantly higher in OSCC tumors than in adjacent normal tissues.
- Elevated TIMP levels in OSCC correlate with increased metastatic potential and regional lymph node involvement.
- While some indirect MMIs show promise in preclinical studies, their clinical application in OSCC remains limited.
Conclusions:
- TIMP expression is dysregulated in OSCC and serves as a potential biomarker for metastatic risk.
- Further investigation into the therapeutic potential of exogenous TIMPs and other MMIs is warranted for OSCC treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:17The Tumor Microenvironment